SRPT
Price
$63.51
Change
+$0.73 (+1.16%)
Updated
May 2 closing price
Capitalization
6.24B
2 days until earnings call
TECX
Price
$21.75
Change
+$2.09 (+10.63%)
Updated
May 2 closing price
Capitalization
406.01M
Ad is loading...

SRPT vs TECX

Header iconSRPT vs TECX Comparison
Open Charts SRPT vs TECXBanner chart's image
Sarepta Therapeutics
Price$63.51
Change+$0.73 (+1.16%)
Volume$1.4M
Capitalization6.24B
Tectonic Therapeutic
Price$21.75
Change+$2.09 (+10.63%)
Volume$309.5K
Capitalization406.01M
SRPT vs TECX Comparison Chart
Loading...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRPT vs. TECX commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRPT is a Hold and TECX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (SRPT: $63.51 vs. TECX: $21.75)
Brand notoriety: SRPT: Notable vs. TECX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRPT: 59% vs. TECX: 133%
Market capitalization -- SRPT: $6.24B vs. TECX: $406.01M
SRPT [@Biotechnology] is valued at $6.24B. TECX’s [@Biotechnology] market capitalization is $406.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRPT’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 0 green FA rating(s).

  • SRPT’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, TECX is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRPT’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 5 bullish TA indicator(s).

  • SRPT’s TA Score: 4 bullish, 4 bearish.
  • TECX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TECX is a better buy in the short-term than SRPT.

Price Growth

SRPT (@Biotechnology) experienced а +5.08% price change this week, while TECX (@Biotechnology) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

SRPT is expected to report earnings on Jul 30, 2025.

TECX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($6.24B) has a higher market cap than TECX($406M). SRPT YTD gains are higher at: -47.767 vs. TECX (-52.902). SRPT has more cash in the bank: 1.36B vs. TECX (159M). TECX has less debt than SRPT: TECX (2.98M) vs SRPT (1.34B).
SRPTTECXSRPT / TECX
Capitalization6.24B406M1,537%
EBITDA317MN/A-
Gain YTD-47.767-52.90290%
P/E Ratio27.14N/A-
Revenue1.9BN/A-
Total Cash1.36B159M852%
Total Debt1.34B2.98M45,007%
FUNDAMENTALS RATINGS
SRPT vs TECX: Fundamental Ratings
SRPT
TECX
OUTLOOK RATING
1..100
917
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
46100
PRICE GROWTH RATING
1..100
6534
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (40) in the null industry is in the same range as SRPT (70) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for TECX (100) in the null industry. This means that SRPT’s stock grew somewhat faster than TECX’s over the last 12 months.

TECX's Price Growth Rating (34) in the null industry is in the same range as SRPT (65) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECX's P/E Growth Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRPTTECX
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
77%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVSKX49.641.08
+2.22%
Fidelity Value Strategies K
DCZRX27.650.49
+1.80%
Macquarie Small Cap Core R6
EMCCX53.600.67
+1.27%
Empiric Class C
JRSNX11.400.13
+1.15%
JH Adaptive Risk Mgd U.S. Eq N
SCNUX10.860.11
+1.02%
Invesco Income Advantage U.S. Fund Inv

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with GLMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+1.16%
GLMD - SRPT
51%
Loosely correlated
-2.34%
ALZN - SRPT
49%
Loosely correlated
+0.74%
TECX - SRPT
46%
Loosely correlated
+10.61%
INSM - SRPT
44%
Loosely correlated
-0.47%
AXON - SRPT
43%
Loosely correlated
+1.14%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with SRPT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+10.61%
SRPT - TECX
46%
Loosely correlated
+1.16%
IGC - TECX
45%
Loosely correlated
-1.57%
MMIRF - TECX
28%
Poorly correlated
N/A
ANEB - TECX
28%
Poorly correlated
-2.54%
GOVX - TECX
24%
Poorly correlated
+2.09%
More